Our spring 2024 edition is now out! We spotlight how we are keeping infants, children and young people safe as they access health services. Plus a welcome return of our regular “Starter for Ten” and “Day In The Life” features.
Whether you're a trainee, SAS doctor or consultant, explore our current volunteering opportunities: a new Officer for Ireland and International Officer, plus roles in supporting training, invited reviews and more.
Packed with top tips and resources from paediatricians of all levels, plus how to take advantage of free RCPCH membership as a medical student or foundation doctor. #ChoosePaediatrics
2023 was a challenging year in medicine, but we worked alongside you, our members, on some huge achievements, from the new training curriculum, Progress+ to our campaign on youth vaping.
Our new 'hub' helps specialty groups develop a guideline for RCPCH endorsement - including running the search, formulating the recommendations and consulting with stakeholders.
Let's work together to make sure children are as safe as they can be from these potentially serious illnesses. We invite you to download our poster and to talk with families about immunisations.
Childhood mental health problems are common and increasing across the UK. We outline the role for paediatricians in prevention, early recognition and holistic care, and we call for greater investment.
Dr Emily Parker is one of our new Clinical Fellows with the Clean Air Fund Partnership, and in her first blog, she describes how doctors are taking a more critical look at the impact of air pollution on children's health.
We've refreshed the RCPCH manifesto to support children’s health and wellbeing in a changing world - underpinned by seven pillars from prioritising child health services to tackling climate change.
Steve says, "I am committed to working with members and College staff in advocating for paediatricians and children at every given opportunity, across the UK and around the world."
More than 2,000 healthcare professionals signed our open letter, which urges the Government to implement an immunisation programme for this common but sometimes fatal respiratory virus.
Our resources and documents include training and career guidance, research and audit reports, policy statements, service standards and online learning. You can use the search or filter to find what you're looking for.
Academic training posts offer paediatricians the opportunity to do crucial research in child health. Take a look at our guidance and links to further resources.
The Royal College of Paediatrics and Child Health and British Paediatric Neurology Association has developed this Q&A in light of recent developments in this area. It advises on the legality and safety of cannabis-based products and considers the evidence base for their potential harms and benefits.
It is essential that paediatrics is a 24 hours a day, seven days a week specialty, with the most experienced doctors present at the busiest times. Our report sets out ten standards for high quality, safe and sustainable acute general paediatric services.
As a child or young person, you don't need superpowers! You have the right to be involved in decisions about your care and to be treated by the right people, at the right time, in the right place. It's all in our Facing the Future standards. Why don't you play our game, tell others about your rights...
UK Medicines Information service (UKMI) in conjunction with the Neonatal and Paediatric Pharmacy Group (NPPG) have produced updated guidance on how to dose medication in children who are obese.
Paediatric clinical pharmacologists have expertise in the development of medicines and their safe, rational use. Find out more about this clinical area.
Read about this clinical area and download the syllabi for both sub-specialty and for generic specialty training.
In the UK Paediatric Training Programme it's possible to choose to sub-specialise during specialty training (ST5-ST7). Applications are made through a competitive recruitment process at ST4 or higher, subject to having completed core training (ST1-ST4) and enough time left to complete the required c...
The Medicines and Healthcare products Regulatory Agency (MHRA) “Yellow Card Scheme” is the UK system for collecting and monitoring information on suspected safety concerns or incidents involving side effects from medicines (also known as adverse drug reactions or ADRs) and medical devices.
This page has updated guidance on the medicine, valproate in accordance with regulation changes from the Medicines & Healthcare products Regulatory Agency (MHRA) in January 2024.